Argentina relaxes biotech patent criteria: repeal of INPI Resolution 283/2015
Regulatory background and context Over the past months, Ojam IP has been closely tracking and reporting on the series of regulatory reforms in intellectual property law unfolding in Argentina since the signature of the Reciprocal Trade and Investment Agreement (ARTI) between Argentina and the United States on February 5, 2026. Among its key commitments, the […]
read more